View Post

NCCN: Updated Guidelines Reflect Advances, ‘Immunotherapy Era’ for Breast Cancer

In In The News by Barbara Jacoby

By: Bryant Furlow From: Updates to the National Comprehensive Cancer Network (NCCN) Guidelines® on breast cancer reflect maturing evidence bases and expanding treatment options, including a recently approved immunotherapy regimen for some patients with locally advanced or metastatic disease, according to speakers at the 2019 NCCN Annual Conference, held March 21–23 in Orlando, Florida. “There are many new and emerging options for …